Myomo (MYO) Cash & Equivalents Growth (1y) (2017 - 2025)
Powered by 
Analysis
Myomo (MYO) Cash & Equivalents Growth (1y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 72.43% |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | -40.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -40.57% |
| Sep 30, 2025 | 84.76% |
| Jun 30, 2025 | 150.00% |
| Mar 31, 2025 | 271.11% |
| Dec 31, 2024 | 260.16% |
| Sep 30, 2024 | 1.24% |
| Jun 30, 2024 | -34.73% |
| Mar 31, 2024 | -41.33% |
| Dec 31, 2023 | 28.53% |
| Sep 30, 2023 | -6.85% |
| Jun 30, 2023 | -12.50% |
| Mar 31, 2023 | -28.43% |
| Dec 31, 2022 | -65.56% |
| Sep 30, 2022 | -41.14% |
| Jun 30, 2022 | -25.68% |
| Mar 31, 2022 | -25.49% |
| Dec 31, 2021 | 26.82% |
| Sep 30, 2021 | -5.34% |
| Jun 30, 2021 | 28.31% |
| Mar 31, 2021 | 26.55% |